Elanco Animal Health (ELAN)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Elanco Animal Health is a Healthcare company with a market capitalization of $11.15B.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.40 | $0.34 | +17.6% |
| Q4 2025 | February 24, 2026 | $0.13 | $0.11 | +14.5% |
| Q3 2025 | November 5, 2025 | $0.19 | $0.13 | +46.2% |
| Q2 2025 | August 7, 2025 | $0.26 | $0.20 | +30.0% |
| Q1 2025 | May 7, 2025 | $0.37 | $0.30 | +23.3% |
| Q4 2024 | February 25, 2025 | $0.14 | $0.15 | -5.8% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 35,819,082 | 7.08% | 8.4 | +1.7% |
| June 30, 2026 | 35,223,208 | 6.96% | 6.9 | -1.0% |
| June 15, 2026 | 35,572,526 | 7.03% | 6.4 | +7.3% |
| May 29, 2026 | 33,151,799 | 6.55% | 4.4 | +4.0% |
| May 15, 2026 | 31,873,775 | 6.30% | 3.9 | +30.9% |
| April 30, 2026 | 24,342,462 | 4.90% | 5.8 | -0.9% |
| April 15, 2026 | 24,563,390 | 4.94% | 5.7 | -3.8% |
| March 31, 2026 | 25,535,642 | 5.14% | 3.5 | +49.0% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Elanco Animal Health's market cap?
As of August 13, 2026, Elanco Animal Health (ELAN) has a market capitalization of $11.15B.
Does Elanco Animal Health pay a dividend?
Elanco Animal Health does not currently pay a dividend.
What sector is ELAN in?
Elanco Animal Health is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What is Elanco Animal Health's short interest?
As of the July 15, 2026 FINRA settlement, 35,819,082 ELAN shares were sold short, or 7.08% of shares outstanding. Days to cover: 8.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Elanco Animal Health's revenue?
In its latest reported fiscal year (ending December 31, 2025), Elanco Animal Health reported revenue of $4.71B and net income of -$232.00M.
Ask your own questions about ELAN
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.